MediBuddy posted robust financials for the year ended March 2025, reporting operating revenue of ₹724.6 crore — a 12.3% rise from FY24 — and a marked narrowing of losses as the digital healthcare platform scales its core services while containing costs.
Core healthcare services drive revenue expansion
The Bengaluru-based company’s revenue growth was fuelled by its primary healthcare verticals: online and offline doctor consultations, medicine delivery, diagnostic testing, elective and non‑elective surgeries, and services linked to health insurance. These segments together generated roughly ₹722 crore of operating income in FY25, with an additional ₹2.5 crore from other operating sources.
Non-operating income contributed another ₹18.4 crore, largely from interest on fixed deposits, investment returns and miscellaneous receipts, bringing total income for the year to nearly ₹743 crore. The diversified income mix underlines MediBuddy’s expanding service ecosystem beyond platform transactions.
Costs contained even as operations expand
Total expenditure for FY25 was about ₹879 crore, broadly flat year‑on‑year, reflecting tighter cost control amid growing volumes. Procurement of materials and services remained the largest expense at approximately ₹333 crore, constituting nearly 38% of overall spend.
Employee benefit costs rose modestly to ₹176.8 crore (around an 8% increase), which included roughly ₹6 crore in ESOP-related charges. Other significant outlays were safety and security at ₹42.5 crore, technology and IT infrastructure at ₹32.5 crore, and a combined ₹138.7 crore for advertising, legal and professional fees, depreciation and finance costs.
Losses narrow as margins improve
Disciplined spending and stronger revenue visibility enabled MediBuddy to cut net losses by 37% to about ₹137 crore in FY25, down from ₹215.7 crore a year earlier. The company spent approximately ₹1.21 for every rupee earned, indicating continued efficiency gains while investing for growth.
EBITDA loss narrowed significantly to around ₹103 crore, improving the EBITDA margin to -14.19% from -25.67% in FY24 — a meaningful step toward operating breakeven.
Healthy liquidity and funding support
As of March 2025, MediBuddy held current assets of ₹395.2 crore, including close to ₹80 crore in cash and bank balances, providing headroom to invest in technology, expand service lines and deepen partnerships across India’s health ecosystem.
The company has raised over $190 million from a mix of domestic and international investors to date, funds that have been deployed to scale the platform, enter new service categories and build a pan‑India presence.
Well positioned for long‑term growth
Founded in 2013, MediBuddy has emerged as a prominent player in India’s healthtech sector. With rising digital adoption, growing healthcare awareness and an expanding market for convenient care delivery, the company stands to benefit from long‑term structural trends in the Indian healthcare market.
The FY25 results highlight MediBuddy’s emphasis on sustainable growth, operational discipline and gradual progress toward profitability, making it a watched name in the country’s digital healthcare landscape.
